Effects of clopidogrel, prasugrel and ticagrelor on prevention of stent thrombosis in patients underwent percutaneous coronary intervention: A network meta‐analysis

BACKGROUND: Clopidogrel, prasugrel and ticagrelor, acting on platelet P2Y12 receptor, are commonly used for prevention of stent thrombosis (ST) among patients who underwent percutaneous coronary intervention (PCI). This study aimed to compare the effects of these drugs by a systematic review and net...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenwen, Zhang, Chen, Zhao, Jian, Xu, Xiuxiu, Dang, Heqin, Xiao, Qiang, Li, Yuanmin, Hou, Haifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027588/
https://www.ncbi.nlm.nih.gov/pubmed/33704801
http://dx.doi.org/10.1002/clc.23536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027588/
https://www.ncbi.nlm.nih.gov/pubmed/33704801
http://dx.doi.org/10.1002/clc.23536

Ejemplares similares